查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585727

輸血設備市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

Blood Transfusion Devices Market by Product (Apheresis Device, Blood Bag, Blood Component Separator), End-user (Ambulatory Surgical Centres, Blood Bank, Hospital) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年輸血器材市值為41.2億美元，預計2024年將達44億美元，複合年成長率為7.18%，到2030年將達67億美元。

輸血器械包括用於採集、儲存、處理和輸注血液及其成分的各種設備和器材。這些設備在手術期間控制失血、治療貧血和支持創傷復原方面發揮關鍵作用，凸顯了對這些設備的需求。應用範圍包括醫院、門診手術中心和血庫，最終用戶是醫療保健專業人員，他們要求血液處理和輸血過程的準確性、安全性和效率。輸血設備市場主要是由慢性病盛行率上升、外科手術數量增加以及對捐血和輸血安全意識的增強所推動的。技術進步，例如提高安全性並最大限度減少人為錯誤的自動輸血設備和系統的開發，正在推動市場成長。然而，市場擴張受到與輸血相關的風險（例如感染疾病傳播）以及設備採購和維護相關的高成本的限制。此外，監管挑戰也是市場進入的障礙。儘管面臨這些挑戰，醫療基礎設施正在改善的新興和不斷擴大的市場正在出現機會。公司可以透過專注於適合資源匱乏環境的經濟實惠、攜帶式且易於使用的設備來利用這些機會。生物相容性感測器技術和血液分離技術的改進等領域有望加速創新。此外，投資於醫務人員的培訓計劃可以提高這些設備的採用和最佳使用，透過確保其品質和安全性來使其對醫療機構有吸引力。與監管機構合作並遵守嚴格的安全通訊協定可以提高產品接受度並減少挑戰。該市場的性質是動態的，不斷變化的醫療保健需求和技術進步往往推動創新，這表明競爭激烈的市場具有巨大的探索和策略成長空間。

主要市場統計
基準年[2023] 41.2億美元
預測年份 [2024] 44億美元
預測年份 [2030] 67億美元
複合年成長率（%） 7.18%

市場動態：快速發展的輸血設備市場的關鍵市場洞察

供需的動態交互作用正在改變輸血設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 血液相關疾病和癌症流行
    • 政府支持的意識提升宣傳活動和對血液製品篩檢的需求不斷成長
    • 全球交通事故和手術數量增加
  • 市場限制因素
    • 輸血器具製造成本高
  • 市場機會
    • 技術先進的篩檢分析儀的可用性迅速增加
    • 持續研究改善輸血裝置的功能
  • 市場挑戰
    • 嚴格的核准規定

波特五力：駕馭輸血器材市場的策略工具

波特的五力框架是了解輸血設備市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解輸血設備市場的外部影響

外部宏觀環境因素在塑造輸血器材市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解輸血器材市場競爭狀況

對輸血設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV定位矩陣輸血裝置市場供應商績效評估

FPNV定位矩陣是評估輸血器材市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃輸血設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對輸血設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血液相關疾病和癌症的盛行率

全世界

      • 隨著政府的支持和對經過測試的血液製品的需求，宣傳宣傳活動不斷擴大
      • 世界各地的交通事故和手術數量正在增加。
    • 抑制因素
      • 輸血器生產成本高
    • 機會
      • 技術先進的篩檢分析儀的採用迅速增加
      • 持續研究改善輸血裝置的功能
    • 任務
      • 嚴格核准監理政策
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章輸血設備市場：依產品

  • 血漿分離裝置
  • 血袋
  • 血液成分分離裝置
  • 血液混合器
  • 消耗品和用品
  • 點滴幫浦
  • 病原體減少系統

第7章 輸血設備市場：依最終使用者分類

  • 門診手術中心
  • 血庫
  • 醫院

第8章美洲輸血器械市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太輸血器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲輸血器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • B. Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Ecomed Solutions
  • EryPharm
  • F.Hoffman-La Roche AG
  • Fresenius Kabi Malaysia Sdn. Bhd.
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • Kawasumi Laboratories, Inc.
  • Macopharma
  • Nipro Medical Corporation
  • Ortho-Clinical Diagnostics, Inc.
  • Quotient Suisse SA
  • Sarstedt AG & Co. KG
  • Siemens AG
  • SURU INTERNATIONAL PVT. LTD.
  • Terumo Corporation
Product Code: MRR-521BAA36EADD

The Blood Transfusion Devices Market was valued at USD 4.12 billion in 2023, expected to reach USD 4.40 billion in 2024, and is projected to grow at a CAGR of 7.18%, to USD 6.70 billion by 2030.

Blood transfusion devices encompass a range of equipment and instruments used to collect, store, process, and transfuse blood and its components. The necessity of these devices is underscored by their critical role in addressing blood loss during surgeries, treating anemia, and supporting traumatic injury recovery. Their applications stretch across hospitals, ambulatory surgical centers, and blood banks, with end-users being medical professionals who demand precision, safety, and efficiency in blood handling and transfusion processes. The market for blood transfusion devices is primarily driven by the rising prevalence of chronic diseases, increasing surgical procedures, and growing awareness regarding blood donation and transfusion safety. Technological advancements, such as the development of automated transfusion devices and systems that enhance safety and minimize human error, add momentum to market growth. However, market expansion faces limitations such as the risks associated with blood transfusion, including the transmission of infectious diseases, and the high costs related to device procurement and maintenance. Furthermore, regulatory challenges pose hurdles for market players. Despite these challenges, opportunities are emerging in developing and expanding markets where healthcare infrastructure is improving. Companies can capitalize on these opportunities by focusing on affordable, portable, and easy-to-use devices that suit low-resource settings. Innovation is poised to thrive in areas like biocompatible sensor technology and improved blood separation techniques. Moreover, investing in training initiatives for medical staff could improve the adoption and optimized use of these devices, enticing healthcare facilities with assurances of quality and safety. Collaboration with regulatory bodies and adherence to strict safety protocols can enhance product acceptance and mitigate challenges. The nature of this market is dynamic, with innovations often steered by evolving healthcare needs and technological advancements, suggesting a competitive landscape with robust scope for research and strategic growth.

KEY MARKET STATISTICS
Base Year [2023] USD 4.12 billion
Estimated Year [2024] USD 4.40 billion
Forecast Year [2030] USD 6.70 billion
CAGR (%) 7.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Transfusion Devices Market

The Blood Transfusion Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of blood-related disorders and cancer globally
    • Growing awareness campaigns with government support and demand for screened blood products
    • Rising cases of road accidents and increase in number of surgeries worldwide
  • Market Restraints
    • High cost of production of blood transfusion devices
  • Market Opportunities
    • Surge in availability of technologically advanced screening analyzers
    • Ongoing research to improve the functionality of blood transfusion devices
  • Market Challenges
    • Strict regulatory policies for approval

Porter's Five Forces: A Strategic Tool for Navigating the Blood Transfusion Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Transfusion Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Transfusion Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Transfusion Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Transfusion Devices Market

A detailed market share analysis in the Blood Transfusion Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Transfusion Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Transfusion Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Transfusion Devices Market

A strategic analysis of the Blood Transfusion Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Transfusion Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Ecomed Solutions, EryPharm, F.Hoffman-La Roche AG, Fresenius Kabi Malaysia Sdn. Bhd., Fresenius SE & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Jiangsu Kangjin Medical Instrument Co.,Ltd., Kawasumi Laboratories, Inc., Macopharma, Nipro Medical Corporation, Ortho-Clinical Diagnostics, Inc., Quotient Suisse SA, Sarstedt AG & Co. KG, Siemens AG, SURU INTERNATIONAL PVT. LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Transfusion Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Apheresis Device, Blood Bag, Blood Component Separator, Blood Mixer, Consumables & Supplies, Infusion Pumps, and Pathogen Reduction System.
  • Based on End-user, market is studied across Ambulatory Surgical Centres, Blood Bank, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of blood-related disorders and cancer

globally

      • 5.1.1.2. Growing awareness campaigns with government support and demand for screened blood products
      • 5.1.1.3. Rising cases of road accidents and increase in number of surgeries worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of blood transfusion devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in availability of technologically advanced screening analyzers
      • 5.1.3.2. Ongoing research to improve the functionality of blood transfusion devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory policies for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Transfusion Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Apheresis Device
  • 6.3. Blood Bag
  • 6.4. Blood Component Separator
  • 6.5. Blood Mixer
  • 6.6. Consumables & Supplies
  • 6.7. Infusion Pumps
  • 6.8. Pathogen Reduction System

7. Blood Transfusion Devices Market, by End-user

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centres
  • 7.3. Blood Bank
  • 7.4. Hospital

8. Americas Blood Transfusion Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood Transfusion Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood Transfusion Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun SE
  • 3. Baxter International Inc.
  • 4. Becton Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Ecomed Solutions
  • 8. EryPharm
  • 9. F.Hoffman-La Roche AG
  • 10. Fresenius Kabi Malaysia Sdn. Bhd.
  • 11. Fresenius SE & Co. KGaA
  • 12. Grifols, S.A.
  • 13. Haemonetics Corporation
  • 14. Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • 15. Kawasumi Laboratories, Inc.
  • 16. Macopharma
  • 17. Nipro Medical Corporation
  • 18. Ortho-Clinical Diagnostics, Inc.
  • 19. Quotient Suisse SA
  • 20. Sarstedt AG & Co. KG
  • 21. Siemens AG
  • 22. SURU INTERNATIONAL PVT. LTD.
  • 23. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. BLOOD TRANSFUSION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TRANSFUSION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD TRANSFUSION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD MIXER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONSUMABLES & SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023